UTP18 inhibitors are a specialized class of chemical compounds designed to interact with and inhibit the activity of the UTP18 protein. UTP18 is part of a complex involved in ribosome biogenesis, playing a crucial role in the assembly and processing of small ribosomal subunits within the nucleolus. Inhibitors targeting UTP18 are developed to disrupt its function, impacting the processes associated with ribosome production and maturation. The design of UTP18 inhibitors often involves intricate chemical structures, including a variety of functional groups and ring systems, tailored to specifically bind to the active or allosteric sites of the UTP18 protein.
The chemical composition of UTP18 inhibitors typically includes aromatic rings, heterocyclic systems, and other groups that promote strong binding interactions with UTP18. These compounds are often synthesized using advanced organic chemistry techniques, including multi-step synthesis and combinatorial chemistry. The inhibitors are designed to engage in specific molecular interactions, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, to ensure high affinity and selectivity for UTP18. Researchers utilize molecular docking and structure-based design strategies to optimize the inhibitors, refining their chemical properties to improve binding efficiency. By targeting UTP18, these inhibitors provide a useful tool for studying the mechanisms underlying ribosome assembly and exploring the broader biological implications of disrupting UTP18's role in this complex cellular process.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that can affect cell growth and proliferation, potentially altering the expression or activity of UTP18. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that can disrupt signaling pathways, possibly influencing the cellular processes in which UTP18 is involved. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases, potentially affecting the phosphorylation state of UTP18. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can disrupt protein synthesis, possibly influencing the expression levels of UTP18. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
An inhibitor of eukaryotic protein synthesis that can decrease the overall protein levels, potentially reducing UTP18 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
An inhibitor of RNA polymerase that prevents mRNA synthesis, potentially decreasing the expression of UTP18. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially disrupting calcium homeostasis and affecting UTP18's function. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
An inhibitor of ADP-ribosylation factor (ARF), which can disrupt Golgi apparatus function, potentially affecting the trafficking and function of UTP18. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A specific inhibitor of MEK that can block the MAPK/ERK pathway, potentially affecting signaling pathways involving UTP18. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Another MEK inhibitor that can disrupt the MAPK/ERK signaling, potentially modulating the activity or expression of UTP18. | ||||||